S-1 and irinotecan with or without bevacizumab versus 5-fluorouracil and leucovorin plus oxaliplatin with or without bevacizumab in metastatic colorectal cancer: a pooled analysis of four phase II studies
Crossref DOI link: https://doi.org/10.1007/s00280-015-2834-4
Published Online: 2015-07-29
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Iwasa, Satoru
Nagashima, Kengo
Yamaguchi, Tatsuro
Matsumoto, Hiroshi
Ichikawa, Yasushi
Goto, Ayumu
Yasui, Hisateru
Kato, Ken
Okita, Natsuko Tsuda
Shimada, Yasuhiro
Yamada, Yasuhide
Text and Data Mining valid from 2015-07-29